Seller, A.; Tegeler, C.M.; Mauermann, J.; Schreiber, T.; Hagelstein, I.; Liebel, K.; Koch, A.; Heitmann, J.S.; Greiner, S.M.; Hayn, C.;
et al. Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. Int. J. Mol. Sci. 2024, 25, 4126.
https://doi.org/10.3390/ijms25074126
AMA Style
Seller A, Tegeler CM, Mauermann J, Schreiber T, Hagelstein I, Liebel K, Koch A, Heitmann JS, Greiner SM, Hayn C,
et al. Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International Journal of Molecular Sciences. 2024; 25(7):4126.
https://doi.org/10.3390/ijms25074126
Chicago/Turabian Style
Seller, Anna, Christian M. Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S. Heitmann, Sarah M. Greiner, Clara Hayn,
and et al. 2024. "Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome" International Journal of Molecular Sciences 25, no. 7: 4126.
https://doi.org/10.3390/ijms25074126
APA Style
Seller, A., Tegeler, C. M., Mauermann, J., Schreiber, T., Hagelstein, I., Liebel, K., Koch, A., Heitmann, J. S., Greiner, S. M., Hayn, C., Dannehl, D., Engler, T., Hartkopf, A. D., Hahn, M., Brucker, S. Y., Salih, H. R., & Märklin, M.
(2024). Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International Journal of Molecular Sciences, 25(7), 4126.
https://doi.org/10.3390/ijms25074126